Capital Market Strategies »

Crispr Therapeutics shares owned by Capital Market Strategies

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Capital Market Strategies from 13F filings

Historical chart of Capital Market Strategies investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Capital Market Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Capital Market Strategies

Quarter filed Position value Share count Share price at filing
2025-06-30 $988k 20k 48.64
2025-03-31 $727k 21k 34.03
2024-12-31 $461k 12k 39.36

More positions owned by Capital Market Strategies

Ishares Tr Fltg Rate Nt Etf (FLOT)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
First Bank (FRBA)
Palantir Technologies Cl A (PLTR)
Etf Opportunities Trust Applied Fina Val (VSLU)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Costco Wholesale Corporation (COST)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Invesco Exchange Traded Fd T S&p500 Eql Tec (RSPT)
Ishares Tr Core S&p Ttl Stk (ITOT)
Axon Enterprise (AXON)
Amazon (AMZN)
Broadcom (AVGO)

View all positions for Capital Market Strategies

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
Susquehanna International
Sr One Capital Management
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics